Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids
Authors
Keywords
Breast cancer, Personalized medicine, Preclinical treatment selection, In vitro diagnostics, Spheroid cell culture
Journal
Journal of Translational Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-03
DOI
10.1186/s12967-016-0855-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer Version 3.2014
- (2017) William J. Gradishar et al. Journal of the National Comprehensive Cancer Network
- Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K
- (2016) Sara Lahsaee et al. EXPERIMENTAL CELL RESEARCH
- A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
- (2015) Michael D. Alvarado et al. ADVANCES IN THERAPY
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Gene-Expression-Based Predictors for Breast Cancer
- (2015) Arjun Gupta et al. ANNALS OF SURGICAL ONCOLOGY
- Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study
- (2015) Kathrin Halfter et al. BMC CANCER
- Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer
- (2015) Soo Youn Bae et al. BMC CANCER
- Time-lapse imaging assay using the BioStation CT: A sensitive drug-screening method for three-dimensional cell culture
- (2015) Ruriko Sakamoto et al. CANCER SCIENCE
- Impact of the spheroid model complexity on drug response
- (2015) Oliver Ingo Hoffmann et al. JOURNAL OF BIOTECHNOLOGY
- Evaluation of chemotherapeutics in a three-dimensional breast cancer model
- (2015) Carrie J. Lovitt et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Portrait of Breast-Cancer-Derived Cell Lines Reveals Poor Similarity with Tumors
- (2015) Paolo Cifani et al. JOURNAL OF PROTEOME RESEARCH
- Precision Medicine in Breast Cancer: Genes, Genomes, and the Future of Genomically Driven Treatments
- (2015) Daniel G. Stover et al. Current Oncology Reports
- Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening
- (2015) Maria A. Theodoraki et al. Oncotarget
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial
- (2014) Antonio Llombart-Cussac et al. BREAST
- Predicting response and survival in chemotherapy-treated triple-negative breast cancer
- (2014) A Prat et al. BRITISH JOURNAL OF CANCER
- Mouse Models of Human Cancer
- (2014) Barbara C. Böck et al. CANCER RESEARCH
- Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment
- (2014) D. Herrmann et al. CARCINOGENESIS
- Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2014) J. R. Brown et al. CLINICAL CANCER RESEARCH
- Organoid cultures for the analysis of cancer phenotypes
- (2014) Norman Sachs et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature
- (2014) C.A. Drukker et al. EUROPEAN JOURNAL OF CANCER
- TBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2-Negative Primary Operable Breast Cancer
- (2014) R. M. Connolly et al. JOURNAL OF NUCLEAR MEDICINE
- Promoting Quality and Evidence-Based Care in Early-Stage Breast Cancer Follow-up
- (2014) L. N. Henry et al. JNCI-Journal of the National Cancer Institute
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Engineering Mammary Gland in Vitro Models for Cancer Diagnostics and Therapy
- (2014) Jonathan J. Campbell et al. MOLECULAR PHARMACEUTICS
- Personalized In Vitro Cancer Modeling — Fantasy or Reality?
- (2014) Richard Bartlett et al. Translational Oncology
- Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer
- (2014) Lindsey J. Graham et al. Journal of Cancer
- Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
- (2013) C. Denkert et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
- (2013) Yi Liu et al. BMC CANCER
- One mouse, one patient paradigm: New avatars of personalized cancer therapy
- (2013) Prerna Malaney et al. CANCER LETTERS
- Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
- (2013) N. Harbeck et al. EUROPEAN JOURNAL OF CANCER
- A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer
- (2013) Thomas Rutherford et al. GYNECOLOGIC ONCOLOGY
- Surrogate endpoints in metastatic breast cancer treated with targeted therapies: an analysis of the first-line phase III trials
- (2013) Fausto Petrelli et al. MEDICAL ONCOLOGY
- Development of a High-Throughput Three-Dimensional Invasion Assay for Anti-Cancer Drug Discovery
- (2013) Nikki A. Evensen et al. PLoS One
- Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation
- (2013) Clement Chung et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
- (2012) Nehmat Houssami et al. EUROPEAN JOURNAL OF CANCER
- Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice
- (2012) Domenico Angelucci et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Current and emerging biomarkers in breast cancer: prognosis and prediction
- (2010) Marion T Weigel et al. ENDOCRINE-RELATED CANCER
- Multicellular tumor spheroids: An underestimated tool is catching up again
- (2010) Franziska Hirschhaeuser et al. JOURNAL OF BIOTECHNOLOGY
- Capecitabine in Addition to Anthracycline- and Taxane-Based Neoadjuvant Treatment in Patients With Primary Breast Cancer: Phase III GeparQuattro Study
- (2010) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer
- (2009) Marcus C. Tan et al. AMERICAN JOURNAL OF SURGERY
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now